This study tests a new drug called rosnilimab in 132 adults with moderate to severe ulcerative colitis. The goal is to see if it can reduce disease activity and improve symptoms compared to a placebo. Participants must have tried other treatments without success. The trial is act…
Phase: PHASE2 • Sponsor: AnaptysBio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC